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Studies performed to discover genes overexpressed in inflammatory diseases identified dermokine as being
upregulated in such disease conditions. Dermokine is a gene that was first observed as expressed in the
differentiated layers of skin. Its two major isoforms, a and b, are transcribed from different promoters of the
same locus, with the a isoform representing the C terminus of the b isoform. Recently, additional transcript
variants have been identified. Extensive in silico analysis and reverse transcriptase (RT)-PCR cloning has
confirmed the existence of these variants in human cells and tissues, identified a new human isoform as well as
the g isoform in mouse. Recombinant expression and analysis of the C-terminal truncated isoform indicate that
the molecule is O-linked glycosylated and forms multimers in solution. In situ hybridization and
immunohistochemistry has shown that the gene is differentially expressed in various cells and tissues, other
than the skin. These results show that the dermokine gene is expressed in epithelial tissues other than the skin
and this expression is transciptionally and posttranscriptionally complex.
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INTRODUCTION
Many inflammatory diseases are characterized by the over-
expression of classical mediators of immune cell activation.
In addition, many other genes have been shown to be
differentially regulated in such conditions, and are either not
well characterized or are not thought of as components of
immune function or inflammatory states.
We recently embarked on a search for novel genes that are
differentially regulated in inflammatory conditions. One such
gene identified in this search was determined to be identical
to a recently reported skin-specific gene, dermokine (results
to be reported in a separate paper). Dermokine (sk89/30) was
mapped to human chromosome 19q13.12, which harbors a
number of epidermal-specific genes (Matsui et al., 2004;
Moffat et al., 2004). In situ hybridization revealed that the
gene is expressed mainly in the spinous and granular layers of
the epidermis (Matsui et al., 2004; Moffat et al., 2004).
Dermokine has been reported to be encoded by 18 exons,
spanning 17 kb of genomic DNA (Matsui et al., 2004; Moffat
et al., 2004). Two separate isoforms have been identified for
this gene, denoted a and b, with the a isoform (7 kDa)
representing the C-terminal domain of the b isoform (45 kDa)
and possessing its own promoter (Matsui et al., 2004; Moffat
et al., 2004). The a and b isoforms appear to have
overlapping expression patterns in the epidermis (Matsui
et al., 2004; Moffat et al., 2004). Although both isoforms have
no significant homology to other proteins, the a isoform
(C terminus of dermokine b) has some biochemical properties
common with certain cytokines (Matsui et al., 2004).
Recently, additional isoforms have been identified and
include a C-terminal truncated form (g) as well as isoforms
originating from a third transcription start site that lack a
putative signal sequence and do not appear to be secreted
(Toulza et al., 2006).
In an effort to understand better the biology of
this molecule, we performed an extensive in silico analysis
of this gene and analyzed its expression in various cell
lines and tissues. Utilizing various bioinformatics tools, we
have identified exons that are differentially spliced in various
cells and tissues and confirmed the existence of the
recently identified g and d isoforms as well as a fifth isoform,
e, that utilizes the second transcription start site and first
termination site. Sequence analysis of cloned transcripts
originating from the second transcription start site
(d and e isoforms) revealed complex messages that lack
predicted signal sequences. The g C-terminal truncated
isoform is conserved in the mouse gene as well.
Expression analysis of this gene and its possible isoforms
indicates that it is expressed in a variety of cells and
tissues of mainly epithelial origin. In addition, analysis of
recombinantly expressed g isoform indicates that it is
O-linked glycosylated and forms multimers in solution. This
information will aid in understanding the biology of this
complex gene.
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RESULTS AND DISCUSSION
We have identified a number of genes that are differentially
regulated in inflammatory states (data to be reported in a
separate paper). Sequence analysis of one such gene
identified it as dermokine. Dermokine was identified as a
gene that is expressed in the suprabasal layers of the
epidermis, more specifically, in the spinous and granular
layers (Matsui et al., 2004; Moffat et al., 2004). The a and b
isoforms of this gene are unique in that the a isoform, which
encodes only the C-terminal cytokine-like domain of the b
isoform, can be expressed separately through the use of a
separate promoter present in the non-coding intronic DNA of
the gene after exon 11 (Matsui et al., 2004) or 12 (Moffat
et al., 2004). Recently, additional isoforms and exons have
been identified, including a g isoform that lacks the C
terminus and d isoforms that utilize a third transcription start
site and lack a predicted signal sequence (Toulza et al.,
2006). An in silico analysis of overlapping expressed
sequence tags present in the Incyte databases confirmed the
existence of these other novel isoforms as well as identified a
new isoform and additional possible splice variants of this
gene. To confirm and corroborate the expression of this new
isoform and splice variants in human cells and tissues, we
amplified, cloned and sequenced representative sequences
expressed in A431 cell or adult human skin RNA (Figure 1).
RT-PCR experiments using isoform-specific oligonucleotides
(Table 1) resulted in the amplification of all five isoforms
(Figure 1). Sequence analysis of representive clones from
these studies confirmed the in silico data demonstrating the
existence of these isoforms in human skin and A431 cells as
well as novel differential splicing seen in some of the
isoforms. (Figure 2a). Exons 5 through 8, 10, and 11 in
dermokine b and 6 through 12 in g were found to be
differentially spliced (GenBank accession numbers
EF158319, EF158320, EF158321, and EF158322). Exons 4
through 8 encode a glycine–serine-rich domain that may be
O-linked glycosylated, with the differential splicing possibly
functioning to regulate the size of this domain (see Materials
and Methods). Exon 9 encodes a cysteine residue, one of only
two encoded for in this gene. The other cysteine is in exon 4,
which is not differentially spliced. Exons 10 through 12 have
no homology to any known protein domains and are very
small in size, ranging from 36 to 60 nucleotides in length.
Exon 20 has been found to be differentially spliced in the a, b,
and d isoforms (GenBank accession numbers EF158319,
EF158320, and EF158323). All of the dermokine a transcripts
isolated from human skin RNA or A431 cells lack this exon,
whereas approximately half of dermokine b transcripts
possess this exon in skin and A431 cell RNA. Finally, in
dermokine d and e transcripts, exons 9, 10, 11, and 12 were
found to be differentially spliced (GenBank accession
numbers EF158323, EF158324, EF158325, and EF158326).
Oligo pair specific for:     
2 kb
1 kb 
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Figure 1. Agarose gel analysis of RT-PCR-amplified transcripts expressed in
adult human skin. Molecular weight is a 1-kb DNA ladder. Oligonucleotide
pairs specific for each isoform were used in the analysis and are listed
above the gel image. Arrows and brackets point to bands that were cloned
and sequenced.
Table 1. Sequence and position of oligonucleotides used to amplify human and mouse dermokine isoforms
RT-PCR oligonucleotides Sequence (50–30) Exon (position)
hDermokine ex1f GGCTGGGCAGAGATGAAGTTCCAG 1 (12–12)
hDermokine ex7f ATGCTCGGAATAACTTCCTGCAGCG 7 (1–25)
hDermokine ex18f ATGAAGCCGGCCACTGCCTCTG 18 (1–22)
hDermokine ex23r GCAGGCCAGGTTGCACCCGGG 23 (26–5)
hDermokine ex15r GTCACGGGATGCGAGAGCTTCTCTGG 15 (29–3)
hDermokine ex25rt GGCCAGGGCTGGCACAGGC 25 (92–73)
hDermokine ex15rt TCTGGTGGCTCCTTGTCTGGAGGTC 15 (50–25)
mDermokine ex13f GACAAGGGGAGATCTCACAAACCATGACCTCCAG 13 (1–34)
mDermokine ex22f AACATTCCTTCTAGTCACTGCGGACTCCTCACG 22 (1–33)
mDermokine ex1f ATGAAGCTACAGGGCTCTCTGGC 1 (1–23)
mDermokine ex21r ACCAAAACTTCAGCCACTTCAGCAGGCC 21 (46–18)
mDermokine ex13r GTCATGGTTTGTGAGATCTCCCCTTGTC 13 (28–1)
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In an effort to determine the existence of these novel
isoforms in the mouse ortholog, along with possible
additional exons, we performed a similar in silico analysis,
in addition to rapid amplification of cDNA 30 ends (30 RACE)
and RT-PCR analyses of transcripts from mouse dorsal skin
RNA. Close analysis of the mouse genomic sequence
identified a sequence between exons 12 and 13 that had
homology to human exon 15 (Figure 3a). Initial attempts to
amplify full-length transcripts originating in exon 1 by 30
RACE were unsuccessful. To overcome this, oligonucleotide
primers were designed in exon 21 (22) and in the region with
homology to human exon 15 between exons 12 and 13 and
used to perform 30 RACE studies. Using these primers,
transcripts that possessed polyadenylation signals and tails
were amplified and cloned. Sequencing of these clones
revealed that the sequences amplified using the exon 21 (22)
oligonucleotide terminated as expected, whereas the se-
quences amplified with the new oligonucleotide between
exons 12 and 13 amplified a new terminator (Figure 3b).
These data indicate that the mouse gene possessed an exon
exon 8
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Figure 2. Dermokine gene structure. Schematic representation of (a) the human and (b) mouse dermokine loci. Exons are indicated by filled lines and arrows.
Exons that have been found to be differentially spliced in either the in silico or RT-PCR analysis are indicated by asterisks above it. Representative transcripts
isolated by RT-PCR are shown below the genomic structure. Position of the 50 and 30 in situ hybridization probes are also shown.
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between the old exons 12 and 13 (new exon 13), which
generate a mouse dermokine g molecule. Utilizing this new
sequence information, a new primer was designed in this
new exon and was used to amplify a novel transcript, which
after cloning and sequencing, revealed that it was the mouse
dermokine g isoform (Figure 3c and d). These data indicate
that the g isoform is expressed in mouse skin RNA. However,
the third transcription-initiation site homologous to exon 7 in
the human gene has yet to be identified. To date, there are
two gaps in the mouse genome where such an exon might be
positioned (Figure 2b). Two new mouse dermokine exons,
exon 6 and exon 9, have also been identified in addition to
the new terminator exon. Using either RT-PCR cloning of
mouse dermokine transcripts using isoform-specific oligonu-
cleotides listed in Table 1 (data not shown), or in silico
analysis, both exons have been found to be differentially
spliced (Figure 2b). Although the extent of differential splicing
of the mouse gene is unknown because of the lack of
sequences present in public databases, the novel exons are
homologous to exons that are differentially spliced in the
human gene. Mouse exon 6 is homologous to human exon 6
and mouse exon 9 is homologous to human exon 11.
In all, the human and mouse dermokine genes consist of
25 and 22 exons, respectively (Figure 2a and b). Perhaps the
most interesting aspect of this gene is the differential use of
promoters and terminators to generate isoforms with unique
cellular distributions and domain compliments. Most of the
data presented here are in agreement with the data from
Toulza et al. (2006), with a few minor exceptions. As noted
above, we identified splice variants of dermokine b both in
the Incyte database and in skin and A431 cells, which Toulza
et al. (2006) did not. In addition, we found dermokine g
transcripts that differentially expressed exons 6 and 8.
However, the most complicated differences are among the
dermokine d and e transcripts. We have found that dermokine
d and the newly identified dermokine e originates in exon 7,
whereas Toulza et al. (2006) reported that dermokine d
originates in exon 6. Dermokine d transcripts deposited in
Genebank initiate in exon 7. This discrepancy remains to be
clarified. Also, it is noteworthy that we have found that the
D K G R S H K P
tttctctgctcagGACAAGGGGAGATCTCACAAACCATGAcctccagatgaggagctaccgctccatgagagacccaccattccatcacc
cctaactcttacccttctccctggaaataaattgtagct
a
D K G R S H K P
GACAAGGGGAGATCTCACAAACCAtgacctccagatgaggagctaccagctccatgagagacccaccattccatcacccctaactcttacccttct
ccctggaaataaattgtagctgccccataaaaaaaaaaaaaaaaaaaaaaaaa
Exon 13b
c
M K L Q  G  S  L A C L L L A L  C  L  G G G A A N P L  H  S  G G E G  T  G  A S
1 ATGAAGCTAC AGGGCTCTCT GGCCTGCCTC CTGCTGGCCC TATGTCTGGG TGGTGGGGCA GCTAACCCGC TGCACAGTGG AGGGGAGGGC ACAGGGGCAA
TACTTCGATG TCCCGAGAGA CCGGACGGAG GACGACCGGG ATACAGACCC ACCACCCCGT CGATTGGGCG ACGTGTCACC TCCCCTCCCG TGTCCCCGTT
· A A H G A G  D  A  I  S H G I G E A  V  G  Q  G A K E A A S S G I Q N A L
101 GTGCTGCCCA TGGAGCAGGA GATGCCATTA GCCATGGAAT TGGAGAGGCT GTGGGCCAAG GGGCTAAAGA AGCAGCCAGC TCTGGAATCC AGAATGCCCT
CACGACGGGT ACCTCGTCCT CTACGGTAAT CGGTACCTTA ACCTCTCCGA CACCCGGTTC CCCGATTTCT TCGTCGGTCG AGACCTTAGG TCTTACGGGA
· S  Q  G H G E E S G S  T  L  M G S R G D V F  E  H  R L G E A A R S  L  G  N
201 AAGCCAGGGG CACGGAGAGG AAAGTGGCTC CACATTGATG GGGAGCAGAG GCGATGTTTT TGAGCACCGG CTTGGGGAAG CAGCAAGATC TCTGGGGAAC
TTCGGTCCCC GTGCCTCTCC TTTCACCGAG GTGTAACTAC CCCTCGTCTC CGCTACAAAA ACTCGTGGCC GAACCCCTTC GTCGTTCTAG AGACCCCTTG
A G N E  I  G  R Q A E D I I R  Q  G  V D A V H N A G  S  W  G T S G  G  H  G A
301 GCTGGGAATG AGATTGGCAG ACAGGCTGAG GATATCATTC GCCAAGGGGT AGATGCTGTC CACAACGCTG GGTCCTGGGG GACATCTGGA GGTCATGGCG
CGACCCTTAC TCTAACCGTC TGTCCGACTC CTATAGTAAG CGGTTCCCCA TCTACGACAG GTGTTGCGAC CCAGGACCCC CTGTAGACCT CCAGTACCGC
· Y G S Q G G  A  G  V  Q G N P G P Q  G  T  P  W A S G G N Y G T N S L G G
401 CATATGGCTC TCAAGGTGGT GCTGGAGTCC AGGGCAATCC TGGTCCTCAA GGGACACCCT GGGCCTCAGG AGGCAACTAT GGGACTAACT CTCTGGGTGG
GTATACCGAG AGTTCCACCA CGACCTCAGG TCCCGTTAGG ACCAGGAGTT CCCTGTGGGA CCCGGAGTCC TCCGTTGATA CCCTGATTGA GAGACCCACC
· S  V  G Q G G N G G P  L  N  Y E T N A Q G A  V  A  Q P G Y G T  V  R G N  N
501 CTCTGTGGGT CAGGGTGGCA ATGGCGGACC ACTCAACTAT GAAACCAATG CCCAGGGAGC TGTGGCTCAG CCTGGCTACG GGACAGTGAG AGGCAACAAC
GAGACACCCA GTCCCACCGT TACCGCCTGG TGAGTTGATA CTTTGGTTAC GGGTCCCTCG ACACCGAGTC GGACCGATGC CCTGTCACTC TCCGTTGTTG
Q N S G  C  T  N P P P S G S H  E  S  F S N S G G S S  N  D  G S R G  S  Q  G S
601 CAGAACTCAG GGTGTACCAA CCCCCCACCT TCTGGCTCCC ATGAAAGCTT CAGTAACTCT GGGGGAAGCA GCAATGATGG CAGTCGTGGT AGCCAAGGCA
GTCTTGAGTC CCACATGGTT GGGGGGTGGA AGACCGAGGG TACTTTCGAA GTCATTGAGA CCCCCTTCGT CGTTACTACC GTCAGCACCA TCGGTTCCGT
· H G S N G Q  G  S  S  G R G G G Q G  N  S  G  G T G S R G G S G G S G G S
701 GTCATGGCAG TAATGGTCAG GGCAGCAGCG GTAGAGGCGG TGGCCAAGGC AACAGCGGGG GAACCGGCAG CAGGGGTGGA AGTGGTGGAA GTGGTGGAAG
CAGTACCGTC ATTACCAGTC CCGTCGTCGC CATCTCCGCC ACCGGTTCCG TTGTCGCCCC CTTGGCCGTC GTCCCCACCT TCACCACCTT CACCACCTTC
· G  G  G N K P E C N N  P  G  N D V R M A G G  S  G  S Q E S K E S S  H  L  L
801 TGGTGGTGGA AACAAACCCG AGTGTAACAA CCCAGGGAAT GATGTGCGCA TGGCCGGAGG ATCTGGGAGT CAGGAAAGTA AAGAAAGCAG TCATCTCCTT
ACCACCACCT TTGTTTGGGC TCACATTGTT GGGTCCCTTA CTACACGCGT ACCGGCCTCC TAGACCCTCA GTCCTTTCAT TTCTTTCGTC AGTAGAGGAA
G G S H  D  Y  Q G H G S N G G  N  I  Q K E A V N G L  N  T  M N S D  A  S  T L
901 GGAGGCTCCC ATGACTACCA GGGGCATGGG TCCAATGGTG GCAATATACA AAAAGAAGCT GTCAATGGAC TCAACACTAT GAACTCGGAT GCATCTACCT
CCTCCGAGGG TACTGATGGT CCCCGTACCC AGGTTACCAC CGTTATATGT TTTTCTTCGA CAGTTACCTG AGTTGTGATA CTTGAGCCTA CGTAGATGGA
· P F N I D N  F  W  E  N L K S K T R  F  I  N  W D A I N K D K G R S H K P
1001 TGCCCTTCAA CATTGACAAT TTCTGGGAGA ATCTTAAGTC CAAGACGCGC TTCATTAACT GGGATGCCAT AAACAAGGAC AAGGGGAGAT CTCACAAACC
ACGGGAAGTT GTAACTGTTA AAGACCCTCT TAGAATTCAG GTTCTGCGCG AAGTAATTGA CCCTACGGTA TTTGTTCCTG TTCCCCTCTA GAGTGTTTGG
· ∗
1101 ATGAC
TACTG
d
Figure 3. Determination of the mouse c isoform. (a) Genomic sequence of the mouse locus showing the potential new termination exon and translation.
(b) Nucleotide and amino-acid translation of the 30 end of clones isolated by 30RACE using an oligonucleotide specific for this new exon. (c) RT-PCR
amplification of the mouse dermokine g. Brackets indicate amplification products cloned and sequenced. Only clones of around 1.2 kb were found to be
specific for mouse dermokine. (d) Nucleotide and translated amino-acid sequence of mouse dermokine g.
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dermokine d and e transcripts reported here have the
potential to utilize different splice acceptors between exons
7 and 8, which can result in alterations in reading frame
(Figure 4). There are two possible splice donors at the end of
exon 7 (Figure 4a). Previously reported transcripts utilize the
first donor (Figure 4b), whereas we have isolated transcripts
that utilize the second (Figure 4c) or read all the way through
the intron between exons 7 and 8, creating a larger exon 7
(Figure 4d). The main consequence of this is a larger 50
untranslated region for these transcripts, which might have
regulatory functions. We have found the first in-frame
methionine for the dermokine e transcripts described here
to reside in exon 13. In comparison, the dermokine d
transcripts reported by Toulza et al. (2006) utilize a start
methionine in what appears to be exon 12. Regardless, these
theoretical proteins are not predicted to encode a signal
sequence and, therefore, might not be secreted. Considering
they contain residues shared with isoforms that are secreted,
it will be interesting to see if they are indeed expressed in
cells or tissues under normal physiologic conditions or have
some novel function at the RNA level.
The expression of this unique gene in the suprabasal layers
of the epidermis has been confirmed by in situ hybridization
(Matsui et al., 2004; Moffat et al., 2004) and immunohisto-
chemistry (Toulza et al., 2006). Specifically, the gene appears
to be expressed in the spinous and granular layers of the
differentiated epidermis. In addition, both dermokine a and b
isoforms have been shown to be upregulated during wild-
type normal keratinocyte differentiation induced by either
high calcium or culture density (Matsui et al., 2004).
However, the expression of this gene in other cells and
tissues is not fully understood.
To identify cells expressing this gene, in situ hybridization
was performed on various adult human tissues. Using
riboprobes to both the 50 and 30 ends of the human dermokine
gene (Figure 2a), which would detect dermokine a, b, g, and d
isoforms, we were able to confirm expression of this gene in
various epithelial tissues. Dermokine expression was de-
tected in the differentiated layers of the epidermis (arrow,
Figure 5a, sense-probe labeling in Figure 5b). Specifically,
dermokine expression localized to the spinous and granular
layers of the epidermis. In addition, dermokine expression
was seen in the epithelia of the small intestine (arrow, Figure
5c), macrophages of the lung (arrow, Figure 5d), and
endothelial cells of the lung (arrow head, Figure 5d). Specific
dermokine labeling could also be detected in the ductal
epithelium of breast tissue (arrow, Figure 5e), the tubule
epithelia of the prostate (arrow, Figure 5f), the parenchymal
epithelia of the liver (arrow, Figure 5g), and the acinar cells of
the pancreas (arrow, Figure 5h).
Dermokine has no homology to other genes. To initiate
structural and functional analysis of the protein products from
this gene, the truncated g isoform was recombinantly
expressed in HEK293 cells. The purified recombinant protein
CCCCGGCCTGCGGTGGGCAGCAGCTCAGGTTCTCCAAATCATTGCGTAGTTCCGAATACCCTCGGCCACACCTGGCCTTCTCCATGC
TCGGAATAACTTCCTGCAGCGACCAACAGGCTAAAGAGGGGGAAGgtctggaggttggaaagaggactggaatctgattggggttcc
1 2
aacaaatctgtaacaccgctgggaacgactgggtcccctttaggtcctttaggacagcgtttgaaatcttgctttcccctgcagGGA
TCCAGCACCGGCTCCTCCTCCGGCAACCACGGTGGGAGCGGCGGAGGAAATGGACATAAACCCGGG
CCCCGGCCTGCGGTGGGCAGCAGCTCAGGTTCTCCAAATCATTGCGTAGTTCCGAATACCCTCGGCCACACCTGGCCTTCTCCATGC
TCGGAATAACTTCCTGCAGCGACCAACAGGCTAAAGAGGGGGAAGGGATCCAGCACCGGCTCCTCCTCCGGCAACCACGGTGGGAGCGGCG
GAGGAAATGGACATAAACCCGGG
Exon 8
Exon 8
CCCCGGCCTGCGGTGGGCAGCAGCTCAGGTTCTCCAAATCATTGCGTAGTTCCGAATACCCTCGGCCACACCTGGCCTTCTCCATGC
TCGGAATAACTTCCTGCAGCGACCAACAGGCTAAAGAGGGGGAAGGTCTGGAGGGATCCAGCACCGGCTCCTCCTCCGGCAACCACG
GTGGGAGCGGCGGAGGAAATGGACATAAACCCGGG
Exon 7
Exon 7
Exon 7
Exon 8
CCCCGGCCTGCGGTGGGCAGCAGCTCAGGTTCTCCAAATCATTGCGTAGTTCCGAATACCCTCGGCCACACCTGGCCTTCTCCATGC
TCGGAATAACTTCCTGCAGCGACCAACAGGCTAAAGAGGGGGAAGGTCTGGAGGTTGGAAAGAGGACTGGAATCTGATTGGGGTTCC
AACAAATCTGTAACACCGCTGGGAACGACTGGGTCCCCTTTAGGTCCTTTAGGACAGCGTTTGAAATCTTGCTTTCCCCTGCAGGGA
TCCAGCACCGGCTCCTCCTCCGGCAACCACGGTGGGAGCGGCGGAGGAAATGGACATAAACCCGGG
Exon 8
Exon 7+
a
b
c
d
Figure 4. Differential splice donor usage in dermokine d and e transcripts. (a) Genomic organization of this region including the initiation site in exon 7,
exon 8, and the intron between them. Exons are boxed and are in uppercase, whereas introns are in lowercase. The two different splice donors are underlined
and numbered. (b–d) Three different splice variants isolated from dermokine d and e transcripts.
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was analyzed by SDS-PAGE (Figure 6a), size-exclusion
chromatography light scattering, and surface-enhanced laser
desorption ionization–mass spectrometry (Figure 6b). The
predicted molecular weight of this protein is 37.5 kDa. The
estimated molecular weight from SDS-PAGE analysis under
reducing conditions is closer to 45 kDa (Figure 6a), indicating
that this molecule might be posttranslationally modified.
Additional bands present under non-reducing conditions
indicate that this molecule might form multimers in solution
(Figure 6a, arrows). Bands of around 70 and greater then
110 kDa are evident, suggesting the presence of dimers and
trimers. These multimers, which are reactive with an affinity
purified rabbit anti-dermokine polyclonal antibody prep (see
Materials and Methods and Figure 6a) can be disrupted under
only reducing conditions, indicating that they are probably
covalent in nature. There are two cysteine residues in the
expressed molecule, which might be contributing to such
interactions. This result was confirmed by size-exclusion
chromatography light scattering (data not shown) and
surface-enhanced laser desorption ionization–mass spectro-
metry (Figure 6b). In the mass spectrometry analysis, the main
peak in the non-reduced sample is 37,540 Da, which is in
perfect agreement with the predicted molecular weight.
However, the peak is somewhat broad and has a shoulder
that contains higher molecular weight species that most
probably are glycovariants (see Materials and Methods). The
smaller broad peaks of 76 and 114 kDa are in agreement with
predicted dimer and trimer species (Figure 6b). Also in
agreement with the SDS-PAGE analysis is the effect of
reduction on these multimeric species, which collapse into
one main peak of 37,465 Da. In addition to this multi-
merization, the molecule appears to undergo additional
posttranslational modifications. Enzymatic treatment of the
molecule with O-glycosidases with or without sialidases
liberated carbohydrates, indicating that the molecule is
modified with O-linked carbohydrates as well (Figure 6c).
Currently, it is unknown whether these multimeric species
and posttranslational modifications exist in vivo; however,
Western blot analysis of proteins isolated from human skin
using an affinity purified rabbit polyclonal anti-dermokine
antibody preparation (see Materials and Methods) seems to
indicate that they might exist (Figure 6a, right panel). In
addition to reactive bands of 40 and 50 kDa (dermokine b
and g), there are additional reactive species of approximately
100 kDa and greater, which might be these multimeric-
modified dermokine molecules (Figure 6a).
Polyclonal antibodies against this protein were raised in
rabbits and were used in immunohistochemical analysis to
determine dermokine distribution in human tissues. As the
amino-acid sequence of this protein is shared with both the b,
g, d, and e isoforms, it should react with all four in such an
analysis. This polyclonal antibody was validated using
purified dermokine g (Figure 6a). As shown in Figure 7a
(arrow), intense membrane-associated staining of dermokine
can be seen in the spinous and granular layers of the
epidermis of the skin. The staining is polar in nature, with high
reactivity in the apical surface (Figure 7b, negative control).
Similarly, intense staining is observed in the tubular epithe-
lium of the kidney (arrow, Figure 7c). Punctate, mainly
intracellular dermokine expression can also be found in the
hepatocytes of the liver (arrow, Figure 7d). Intense staining of
macrophages can be seen in lung tissue (arrow, Figure 7e),
corroborating the in situ data in Figure 5d. In addition,
dermokine expression can be seen in the endothelial cells of
the lung (arrow head, Figure 7e). Light expression can be seen
in the acinar cells of the pancreas (Figure 7f) as well as intense
staining of islet cells (Figure 7f, arrow). Both endothelial cells
(arrow) and smooth muscle cells (arrow head) are stained in
blood vessels (Figure 7g), whereas spleen is completely
negative (Figure 7h). It is interesting to note that lung
macrophages are positive (Figures 5d and 7e), whereas spleen
macrophages are negative (Figure 7h). Together, these
findings indicate that the a, b, and g isoforms of dermokine
are most predominantly expressed in tissue epithelium as well
as tissue macrophages, possibly supporting our hypothesis
that dermokine might play a role in inflammatory processes.
a b
c d
e f
g h
Figure 5. In situ hybridization analysis of dermokine expression in various
tissues. A digoxigenin-labeled anti-sense riboprobe specific for the
50 and 30 end of the dermokine b gene was used in the analysis. Dermokine-
specific hybridization is indicated by arrows. (a) skin (arrows to epidermis);
(b) skin with sense-strand as a negative control; (c) gut (arrows to
epithelial cells); (d) lung (arrows on macrophages, arrow-head on endothelial
cells) (e) breast (arrows on epithelial cells); (f) prostate (arrows on
epithelial cells); (g) liver (arrows on hepatocytes); and (h) pancreas (arrows
on acinar cells). All are at original magnification 40 or final
magnification  600. Bar¼25 mm.
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We do not yet know the function of this gene and its
isoforms in physiological and pathophysiological states.
However, the a isoform encodes a very small, secreted
protein of approximately 7 kDa and has been postulated to be
a cytokine (Moffat et al., 2004). The protein does not encode
any cysteine residues nor does it possess a signal for N-linked
glycosylation. However, it is predicted to encode one O-
linked glycosylation site. The b isoform encodes a large
secreted protein of approximately 40–60 kDa that contains
the a isoform at its C terminus, with a novel domain at its N
terminus. These two domains are separated by an extended
domain that has a potential coiled–coiled region with glycine
triplet repeats and a differentially spliced glycine–serine-rich
region that might serve as a site for O-linked glycosylation
(Figure 8a). Close examination of this potential coiled–coiled
region shows that many of the glycine triplet repeats (G-X-Y)
possess proline residues at the X or Y positions, which are
present in collagen and collagen-like molecules (Figure 8b;
Brodsky and Shah, 1995; Perskikova et al., 2000). However,
these repeats are not continuous, and often interrupted,
indicating that this region is not of the fibril-forming type
(Brodsky and Shah, 1995; Perskikova et al., 2000;). The
glycine–serine-rich region is reminiscent of similar stretches
found in certain intermediate filament molecules like keratins
and loricrin as well as a secreted molecule, corneodesmosin.
These sequences are thought to form loop structures and to
mediate adhesion and oligomerization (Steinert et al., 1991;
Korge et al., 1992; Jonca et al., 2002; Caubet et al., 2004). In
addition, many of the serine residues are predicted to be O-
linked glycosylated (Wang et al., 1996; Van den Steen et al.,
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Figure 6. Biochemical characterization of recombinant dermokine gamma. (a, Left panel) SDS-PAGE and Western blot analysis of recombinantly
expressed and purified dermokine g. Three micrograms of purified recombinant dermokine g with a C-terminal Hist tag was run under non-reduced and reduced
conditions on a 4–12% gradient SDS-PAGE gel and transferred to a polyvinylidene fluoride membrane for Western blotting. The Western blot was probed
with the rabbit polyclonal anti-dermokine antibody. Notice the existence of multimers in the non-reduced sample in lane 1, which are confirmed to be
dermokine by the Western blot. Molecular weight standards are indicated to the left of the gel. (a, Right panel) Total human skin proteins were similarly
run under non-reduced conditions and probed with the polyclonal antibody used in the left panel and showing the existence of multimers as well. (b) Matrix-
assisted laser desorption ionization–mass spectrometry analysis of recombinant dermokine g. Matrix-assisted laser desorption ionization–mass spectrometry
was performed under reduced (top) and non-reduced (bottom) conditions. The existence of the multimers seen in the SDS-PAGE analysis is also seen in this
analysis. Molecular weight of individual species is indicated. (c) Carbohydrate analysis of recombinant dermokine g. Expressed and purified dermokine g
was treated with O-glycosidase with and without sialidase. Released glycans were labeled with anthranilic acid and analyzed by HPLC. The peak around
29 minutes corresponds to the O-linked glycans released by either O-glycosidase or sialidase.
1628 Journal of Investigative Dermatology (2007), Volume 127
MF Naso et al.
Dermokine
1998). The function of this potential glycosylation is not
known, but such glycosylation has been postulated to
function in the stability and integrity of extended peptide
sequences (Wang et al., 1996; Van den Steen et al., 1998).
This protein, as mentioned above, only encodes two cysteine
residues, one of which is differentially spliced. These cysteine
residues appear to be significant, as they are conserved in the
mouse and rat genes as well (Matsui et al., 2004; Moffat et al.,
2004). The recently identified g isoform is identical to the b
isoform, minus the C-terminal a cytokine-like domain. This
isoform is conserved in mouse. Finally, based on theoretical
and experimental data, the d and e isoforms do not appear to
be secreted proteins (Toulza et al., 2006). We are currently
investigating the function of these molecules in various
biological systems.
In conclusion, we have identified dermokine as a gene
that is differentially regulated in inflammatory conditions.
Using a combination of in vitro and in silico techniques, we
have identified exons that are differentially spliced and
confirmed the existence of a third transcription-start site and a
second transcription terminator that result in five possible
isoforms. In solution, the g isoform can form multimers and is
posttranslationally modified with O-linked carbohydrates.
This gene is expressed in many epithelial tissues, with the
protein localizing to intracellular or pericellular spaces. The
a, b, and g isoforms are conserved in mouse, which will allow
for in vivo studies to determine the function of this gene in
various biologic and pathophysiologic states.
MATERIALS AND METHODS
The work described in this paper was approved by and conducted
under the regulation of the Centocor Institutional Biosafety
Committee.
Cells and RNA
A431 cells were purchased from American Type Culture Collection
(Manassas, VA) and maintained in DMEM containing 10% fetal calf
serum (Invitrogen Inc., Carlsbad, CA). Normal adult male keratino-
cyte total RNA was purchased from Stratagene Inc. (La Jolla, CA).
Mouse dorsal skin RNA was isolated from normal C57/B6 mice.
RNA extraction and analysis
Total RNA was extracted from cultured cells or tissues using Trizol
extraction reagent according to the manufacturer’s protocol (Invitro-
gen Inc., Carlsbad, CA). Complementary DNAs were generated
using Superscript II reverse transcriptase (Invitrogen Inc., Carlsbad,
CA) after reverse transcription priming of total RNA using dermokine
ex25rt and ex15rt oligonucleotides (Table 1). PCR was carried out
under standard conditions using Platinum Taq enzyme (Invitrogen
Inc.), using the following oligos for the human dermokine gene:
hdermokine ex1f and hdermokine ex25r for dermokine b; hdermo-
kine ex7f, and hdermokine ex25r for hdermokine d; hdermokine
ex18f, and hdermokine ex25r for dermokine a; hdermokine ex1f,
and hdermokine 15r for dermokine g; and hdermokine ex7f and
hdermokine 15r for dermokine e. For the mouse dermokine, the
following oligonucleotide primers (listed in Table 1) were used in the
30 RACE studies: mDermokine ex13f, mDermokine ex22f and
mDermokine ex1f. Oligonucleotide primers mDermokine ex1f and
mDermokine ex21r were used to clone mouse dermokine b, and
mDermokine ex1f and mDermokine ex13r were used to clone
dermokine g. All oligonucleotides were synthesized by MWG Inc.
(High Point, NC). PCR products were TOPO cloned (Invitrogen Inc.,
Carlsbad, CA) for sequencing. Ten isoform-specific clones per TOPO
cloning reaction were sequenced. Sequencing reactions were
performed using ABI BigDye V.3 and run on an ABI3100 Genetic
analyzer (Applied Biosystems, Foster City, CA).
In silico analysis of dermokine variants
Six hundred and twenty-nine expressed sequence tag sequences that
correlate to at least 50 bp of dermokine were collected from LifeSeq
Gold (Incyte) and Unigen databases (http://www.ncbi.nlm.nih.gov/
entrez/query.fcgi?db=unigene). These sequences were aligned to the
genomic sequence of dermokine by SIM4 algorithm (Florea et al.,
1998) with the following parameters: word size 12; limit of score
drop-off¼ 12. The alignment was visually examined in Genome-
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Figure 7. Immunohistochemical analysis of dermokine expression in normal
human tissues. A rabbit polyclonal antibody raised against the dermokine
gamma protein was used to detect dermokine expression. (a) Skin (arrows to
epidermis, note intense labeling in the squamous layer of the epidermis);
(b) skin without primary antibody as a negative control; (c) kidney (arrows
to ductal epithelial cells); (d) liver (arrows on punctate, granular labeling in
the hepatocytes); (e) lung (arrows on macrophages, arrowhead on
endothelial cells): (f) pancreas (arrows on islet cells); (g) vessel (arrows on the
endothelial cells; arrowhead on the smooth muscle cell); and (h) spleen,
showing lack of labeling. All are at original magnification  40 or final
magnification  600. Bar¼25 mm.
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Beanch (Version 2.0, Informax). At least two expressed sequence tag
alignments were required for an exon to be called.
Recombinant expression, purification, and analysis
cDNAs for dermokine g (exons 1–5, 8, 9, 12, and 13) were cloned
into pcDNA3.1mychis (Invitrogen Inc.) using novel restriction sites
present in the vector and cDNA. This expression vector was
sequenced and then transfected into HEK293H cells using Lipofec-
tamine 2000. Using a C-terminal Hist tag, recombinantly expressed
protein was purified on a Talon resin (Invitrogen Inc.). Purified
proteins were analyzed by SDS-PAGE, Western blots using
a monoclonal anti-Myc antibody, matrix-assisted laser desorp-
tion ionization–mass spectrometry, and size-exclusion chromato-
graphy–HPLC.
Glycosylation analysis
O-linked glycosylation was analyzed by first treating the proteins
with O-glycosidase with and without sialidase. The released O-
glycans were labeled with anthranilic acid and analyzed by HPLC.
Rabbit polyclonal antibody preparation
New Zealand rabbits were immunized four times at weeks 0, 2, 7,
and 8 with 100mg of the recombinant dermokine expressed and
purified as described above. Bleeds were taken at weeks 0, 4, 8, and
10 and assayed for titers against the immunogen. Animals were then
killed, and serum was pooled for affinity purification of dermokine-
specific antibodies using the recombinant protein as the capture
reagent on the affinity column. Antibody specificity was assayed by
Western blot using recombinant dermokine.
In situ hybridization
Slides (human skin and human multitissue) with paraffin-embedded
tissue were routinely dewaxed and left to air dry for 30 minutes at
room temperature. The tissues were digested with pepsin (Invitrogen)
for 10 minutes at 371C. Following this digestion, slides were washed
briefly in dH2O and placed into 3% H2O2 for 10 minutes at room
temperature. The slides were thoroughly washed, dehydrated in
alcohols 70–95% for 1 minute each, and then left again to air dry for
30 minutes at room temperature. Each probe was diluted to 15.0 ng/
ml (Table 1) in probe diluent/hybridization solution (Biomeda, Foster
City, CA). Fifty microliters of probe cocktail was added on the tissue
and a cover slip was placed atop the solution. The slides were
denatured for 10 minutes at 951C and then placed in a humidity
chamber (Slide Moat, Boekel Scientific, Feasterville, PA) for a 371C
overnight incubation. After hybridization, the slides were then
immediately placed into a low stringency wash (2 saline saturated
citrate) for 5 minutes at 421C and then into a high stringency wash
(0.1 saline saturated citrate) for 5 minutes at 42oC. The slides were
washed in 1 auto buffer and then incubated with a horseradish
peroxidase anti-dig antibody (anti-digoxigenin-POD, Fab fragments;
Roche, Indianapolis, IN) for 1 hour at room temperature. The slides
were washed and then exposed to 3-30-diaminobenzidine tetra-
hydrochloride chromogen twice for 5 minutes at room temperature.
The slides were routinely stained with hematoxylin and then
dehydrated, cleared in xylene, coverslipped in Permount (Fisher
Scientific, Pittsburg, PA), then photographed under an Olympus
BX50 light microscope. The positive control included a digoxigenin-
labeled mRNA riboprobe, bactin. The negative controls included
(1) the absence of the probe in the probe cocktail; (2) a sense strand
of the targeted probed; and (3) predigestion of the tissues with a high
concentration of RNase (32.5 mg/ml; Sigma, St Louis, MO) for
2 hours at 371C.
Immunohistochemistry
Protocols for immunohistochemistry have been described previously
(D’Andrea et al, 1998). All incubations were performed at room
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Figure 8. Molecular features of dermokine protein isoforms. (a) Proposed domain architecture for dermokine isoforms. (b) Primary amino-acid sequence of the
collagen-like domain. Gly-X-Y repeats are indicated, with proline residues highlighted in bold.
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temperature. After microwaving the slides in Target (Dako,
Carpenturia, CA), the slides were placed in dH2O, then 3% H2O2,
rinsed in 10 automation buffer (Biomeda), treated with avidin
blocking, rinsed in buffer, and treated with biotin blocking
(15 minutes each, from Vector, catalog No. SP-2001). Normal
goat-blocking serum (Vectastain, PK-6101) was then added for
10 minutes. Subsequently, the rabbit polyclonal primary antibody to
58 (or 60) (home-made antibodies) was applied to the slides for
30 minutes. Antibody diluent (Zymed, 00–3118) was substituted as
the primary antibody for the negative control. After several
phosphate-bufferd saline washes, a biotinylated secondary goat
anti-rabbit antibody (Vector Labs, Burlingame, CA) was placed on
the slides for 30 minutes. Subsequently, the slides were washed in
phosphate-bufferd saline and then the avidin–biotin complex (ABC;
Vector Labs, Burlingame, CA) was applied to the slides for
30 minutes. The presence of the primary antibodies was detected
by adding 30-diaminobenzidine HCl (Biomeda) twice, 5 minutes
each. Slides were briefly exposed to Mayer’s hematoxylin (Sigma-
Aldrich, St Louis, MO, MHS-32) for 1 minute, dehydrated and
coverslipped.
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